A generic alternative indicated for oncology support. Biological mechanisms facilitate the management of hormonal balance to provide essential restorative support.
Indicated to address breast cancer growth in postmenopausal women by targeting estrogen production to alleviate disease progression and support long-term remission outcomes effectively.
Mechanism of Action
Exemestane blocks the enzyme aromatase, which converts other hormones into estrogen. By stopping this conversion, the drug deprives hormone-sensitive cancer cells of the estrogen they need to grow and spread.
Route of Administration
Oral
Onset Time
Steady state in 1 week
Duration
24 hours
Contraindications
Premenopausal status, Pregnancy, Hypersensitivity to exemestane, Severe liver disease
Severe Adverse Events
Osteoporosis (bone loss), Severe liver injury, Blood clots, Heart attack risk, Severe allergic reactions, Visual disturbances
Common Side Effects
Hot flashes, Mild fatigue
Uncommon Side Effects
Joint pain, Headache, Increased sweating, Insomnia, Nausea, Bone pain
Drug Interactions
Estrogen therapies, Rifampin, Phenytoin, St. John's Wort, Carbamazepine
Information for Aromasin is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
